NASDAQ:BNTX

BioNTech SE

Stock

102.43 −1.65%

−8.34

USD last updated 22/08 01:43:23

Last Close

110.77

21/08 20:29

Market Cap

19.33B

Beta: 0.22

Volume Today

972.28K

Avg: 618.15K

PE Ratio

7.56

PFCF: 4.40

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	Dec '24
revenue	61.60M -	127.58M 107.11%	108.59M 14.88%	482.32M 344.17%	18.98B 3,834.42%	17.31B 8.78%	3.82B 77.94%	2.75B 27.96%
cost of revenue	94.81M -	156.73M 65.30%	243.83M 55.57%	704.36M 188.88%	3.86B 448.11%	4.53B 17.39%	599.80M 86.77%	541.30M 9.75%
gross profit	-33.22M -	-29.16M 12.23%	-135.24M 363.86%	-222.04M 64.18%	15.12B 6,907.87%	12.78B 15.46%	3.22B 74.81%	2.21B 31.36%
selling and marketing expenses	6.60M -	3.04M 53.95%	2.72M 10.62%	14.51M 433.92%	50.40M 247.30%	59.50M 18.06%	62.70M 5.38%	67.90M 8.29%
general and administrative expenses	22.89M -	24.05M 5.07%	40.69M 69.20%	94.05M 131.12%	278.50M 196.12%	484.70M 74.04%	495M 2.13%	531.10M 7.29%
selling general and administrative expenses	29.49M -	27.09M 8.14%	43.41M 60.24%	108.56M 150.08%	328.90M 202.96%	544.20M 65.46%	557.70M 2.48%	599M 7.41%
research and development expenses	85.50M -	143.04M 67.31%	226.47M 58.32%	645.03M 184.82%	102.70M 84.08%	116M 12.95%	1.78B 1,437.16%	2.25B 26.42%
other expenses			-223.60M -	-893.21M 299.47%	-128.80M 85.58%	-524.30M 307.07%		670.90M -
cost and expenses	122.88M -	181.43M 47.65%	290.11M 59.90%	564.74M 94.67%	4.06B 619.05%	4.67B 14.95%	2.91B 37.56%	4.07B 39.47%
operating expenses	28.06M -	24.70M 11.98%	46.28M 87.38%	-139.62M 401.69%	200.10M 243.32%	135.90M 32.08%	2.31B 1,603.46%	3.52B 52.23%
interest expense	676K -	1.72M 154.59%	1.72M 0.17%	64.95M 3,680.50%	5.40M 91.69%	18.90M 250%	7.74M 59.06%	12.60M 62.83%
ebitda	-48.74M -	-30.01M 38.44%	-146.17M 387.11%	-42.11M 71.19%	14.97B 35,652.26%	13.10B 12.52%	1.16B 91.18%	-367.10M 131.77%
operating income	-61.28M -	-53.85M 12.11%	-181.52M 237.06%	-82.42M 54.60%	15.28B 18,644.48%	12.64B 17.28%	690.40M 94.54%	-1.31B 290.37%
depreciation and amortization	10.53M -	21.98M 108.79%	35.35M 60.80%	40.31M 14.02%	-313.10M 876.77%	453.60M 244.87%	183.40M 59.57%	298M 62.49%
total other income expenses net	-26.03M -	5.97M 122.92%	2.08M 65.17%	-63.38M 3,150.29%	-237.40M 274.54%	311.40M 231.17%	-67.80M 121.77%	636.60M 1,038.94%
income before tax	-85.91M -	-47.66M 44.52%	-179.44M 276.48%	-145.80M 18.75%	15.05B 10,419.75%	12.95B 13.91%	1.19B 90.84%	-677.70M 157.14%
income tax expense	45K -	600K 1,233.33%	-268K 144.67%	-161M 59,974.63%	4.75B 3,052.73%	3.52B 25.96%	255.80M 92.73%	-12.40M 104.85%
net income	-85.65M -	-48.02M 43.94%	-179.17M 273.13%	15.20M 108.48%	10.29B 67,622.73%	9.43B 8.34%	930.30M 90.14%	-665.30M 171.51%
weighted average shs out	226.86M -	226.86M 0%	211.50M 6.77%	253.30M 19.76%	244M 3.67%	243.28M 0.30%	240.60M 1.10%	240.40M 0.08%
weighted average shs out dil	226.86M -	226.86M 0%	211.50M 6.77%	253.30M 19.76%	259.70M 2.53%	249.79M 3.82%	242.70M 2.84%	240.40M 0.95%
eps	-0.38 -	-0.21 44.74%	-0.85 304.76%	0.06 107.06%	42.18 70,200%	38.78 8.06%	3.79 90.23%	-2.77 173.09%
epsdiluted	-0.38 -	-0.21 44.74%	-0.85 304.76%	0.06 107.06%	39.63 65,950%	37.77 4.69%	3.75 90.07%	-2.77 173.87%

All numbers in USD (except ratios and percentages)